The leading global platform for biopharma and medtech regulated digital health products

BrightInsight accelerates time to market for our customers’ digital health products, including apps, algorithms, medical devices, connected combination products, diagnostics, and Software as a Medical Device (SaMD) across therapeutic areas.

Platform wheel graphic mobile
Learn More

BrightInsight Announces Partnership with Sanofi to Bring to Market a Next Generation Digital Companion App

The BrightInsight Platform was selected to accelerate development of one of Sanofi’s Best-In-Class Software as a Medical Device.

Learn More
Homepage sanofi

BrightInsight Named to the 2021 CB Insights Digital Health 150 List of Most Innovative Digital Health Startups

Learn More
Homepage split award digital health 150 2021

BrightInsight Announces $101M in Series C Funding!

Led by General Catalyst, the Financing will Fuel BrightInsight’s Hypergrowth as the Leading Global Regulated Digital Health Platform for Biopharma and Medtech

Learn More
Series c funding 101 M

BrightInsight and CSL Behring Announce Global Digital Health Partnership to Improve Treatment Experience for Patients with Rare Diseases

CSL Behring selects the BrightInsight Platform to build and manage its digital health solutions within a regulatory-compliant environment.

Learn More
Homepage split BICSL Behring logos

How Roche and BrightInsight Launched a Dose Management Software as a Medical Device in 6 months

Watch an on-demand webinar with Paul Upham, Head of Smart Devices at Roche/Genentech, where he discusses how Roche launched a regulated SaMD dosing calculator for treating hemophilia A in Europe.

Dosing calculator


How Biopharma Commercial and R&D Can Partner to Accelerate Digital Innovation

Read More
arrows graphic

COVID-19’s Impact on Digital Health

covid bar graph

Almost 9 out of 10 biopharma leaders say COVID-19 has increased their focus on digital health.

Learn More


Join our award-winning team

View Jobs
BrightInsight brand arrows

Download our latest Industry Brief with Biopharma Dive to hear from industry experts on how to approach the regulatory strategy for your underlying digital health infrastructure.

Using a regulated infrastructure alleviates regulatory concerns as you’re developing your product over years and years. You can be confident that from an infrastructure standpoint, you’ll be compliant.

- Bradley Merrill Thompson, Epstein Becker & Green, P.C.